Showing 5431-5440 of 7863 results for "".
- Care Urged for Adult-Onset AD Diagnoseshttps://practicaldermatology.com/news/Care-Urged-Adult-Onset-AD-Diagnoses/2471216/As revolutionary as the latest approved therapeutics for atopic dermatitis have been, Daniela Kroshinsky, MD, MPH, cautioned that dermatologists must be vigilant and consider biopsies for atypical or nonresponsive cases before starting dupilumab or a JAK inhibitor. Speaking at the Winter C
- 'Dr. Pimple Popper' Offers Social Media Advicehttps://practicaldermatology.com/news/Dr-Pimple-Popper-Offers-Social-Media-Advice/2471209/Social media transformed Sandra Lee, MD, FAAD, FAACS, into “Dr. Pimple Popper.” While not every dermatologist aspires to have their own television show, many would like to maximize the impact of their social media presence, and Dr. Lee shared pearls from her own experience at the Winter Clinical
- Dupixent Moves Closer to FDA Approval for Bullous Pemphigoidhttps://practicaldermatology.com/news/dupixent-moves-closer-to-fda-approval-for-bullous-pemphigoid/2471173/Dupixent® (dupilumab) significantly improved sustained disease remission in adults with bullous pemphigoid (BP) compared to placebo, according to an announcement from the manufacturers, Regeneron Pharmaceuticals and Sanofi. Acc
- Dr. Swanson: Dupilumab/Vaccines Question Has Been Answeredhttps://practicaldermatology.com/news/Dr-Swanson-Dupilumab-Vaccines-Question-Has-Been-Answered/2471166/The biggest remaining question about dupilumab has been answered by the allergy and immunology community, Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, said at the Winter Clinical Hawaii 2025 meeting in Waikoloa Village, Hawaii. “The only realy question
- Analysis: Hydrating Ointment Rivals Steroid Cream in Eczema Severity Reductionhttps://practicaldermatology.com/news/analysis-hydrating-ointment-rivals-steroid-cream-in-eczema-severity-reduction/2471140/New research suggests a petrolatum and panthenol-based ointment (HO) was as effective as 0.1% triamcinolone acetonide in urea cream (TAU) in reducing the severity of mild-to-moderate chronic hand eczema (CHE). Researchers includ
- Hidradenitis Suppurativa Genetics Linked to Cardiometabolic Riskhttps://practicaldermatology.com/news/hidradenitis-suppurativa-genetics-linked-to-cardiometabolic-risk/2471117/A high polygenic risk score (PRS) for hidradenitis suppurativa (HS) is linked to an increased risk of coronary artery disease (CAD) and diabetes, according to a new analysis of UK Biobank data. Study researchers included 391,481 individuals of European ancestry with data in UK Biobank in t
- Skin Cancer Champions Hosts Event to Brainstorm for Growth, Sustainabilityhttps://practicaldermatology.com/news/Skin-Cancer-Champions-Hosts-Event-Brainstorm-Growth-Sustainability/2471116/The Skin Care Champions nonprofit hosted an innovation tournament at Brigham and Women’s Hospital on February 3, bringing together clinicians, patients, caregivers, industry, and more to brainstorm ideas for the organization to achieve growth and sustainability in the future. Emily S. Ruiz
- Galderma Renews Sensitive Skin Care Research Fund at GWhttps://practicaldermatology.com/news/galderma-renews-sensitive-skin-care-research-fund-at-gw/2471114/Galderma extended its partnership with the Department of Dermatology at the George Washington University (GW) School of Medicine and Health Sciences (SMHS) by renewing the Sensitive Skin Care Research Acceleration Fund to support efforts to redefine the understanding and management of this
- New Dupilumab Data for CSU to Be Presented at AAAAI Meetinghttps://practicaldermatology.com/news/New-Dupilumab-Data-CSU-Be-Presented-AAAAI-Meeting/2471105/New phase 3 data on dupilumab for chronic spontaneous urticaria (CSU) will be among 24 abstracts presented by Sanofi at the American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting in San Diego, California, from February 28 to March 3. The dupilumab CSU data from the LIBER
- Analysis: AI Sensor Reduces Scratching in Atopic Dermatitis Patientshttps://practicaldermatology.com/news/ai-sensor-reduces-scratching-in-atopic-dermatitis/2471104/A wearable sensor utilizing artificial intelligence (AI) with haptic feedback significantly reduced nocturnal scratching in adults with mild atopic dermatitis, a new study reports. Researchers for the single-arm, two-stage cohort study recruited 10 adults (60% female; mean age, 36) with at